Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-γ, IP-10 and adenosine deaminase
BACKGROUND: Pleural tuberculosis (PlTB) is the most common extrapulmonary manifestation of this infectious disease which still presents high mortality rates worldwide. Conventional diagnostic tests for PlTB register multiple limitations, including the lack of sensitivity of microbiological methods o...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110466/ https://www.ncbi.nlm.nih.gov/pubmed/30148839 http://dx.doi.org/10.1371/journal.pone.0202481 |
_version_ | 1783350478045708288 |
---|---|
author | Santos, Ana Paula Corrêa, Raquel da Silva Ribeiro-Alves, Marcelo Soares da Silva, Ana Carolina Oliveira Mafort, Thiago Thomaz Leung, Janaína Pereira, Geraldo Moura Batista Rodrigues, Luciana Silva Rufino, Rogério |
author_facet | Santos, Ana Paula Corrêa, Raquel da Silva Ribeiro-Alves, Marcelo Soares da Silva, Ana Carolina Oliveira Mafort, Thiago Thomaz Leung, Janaína Pereira, Geraldo Moura Batista Rodrigues, Luciana Silva Rufino, Rogério |
author_sort | Santos, Ana Paula |
collection | PubMed |
description | BACKGROUND: Pleural tuberculosis (PlTB) is the most common extrapulmonary manifestation of this infectious disease which still presents high mortality rates worldwide. Conventional diagnostic tests for PlTB register multiple limitations, including the lack of sensitivity of microbiological methods on pleural specimens and the need of invasive procedures such as pleural biopsy performance. In this scenario, the search for biological markers on pleural fluid (PF) has been the target of several studies as a strategy to overcome the limitations of PlTB diagnosis. This study aims to evaluate the use either isolated or in combination with adenosine deaminase (ADA), interferon-gamma (IFN-γ), interferon-gamma inducible protein of 10-kD (IP-10) levels on PF in order to guide an accurate anti-TB treatment in microbiologically non-confirmed cases. METHODS AND FINDINGS: Eighty patients presenting pleural effusion under investigation were enrolled in a cross-sectional study conducted at Pedro Ernesto University Hospital, Rio de Janeiro, RJ, Brazil. Peripheral blood (PB) and PF samples collected from all patients were applied to the commercial IFN-γ release assay, QuantiFERON-TB Gold In-Tube, and samples were analyzed for IFN-γ and IP-10 by immunoassays. ADA activity was determined on PF by the colorimetric method. Based on microbiological and histological criteria, patients were categorized as follow: confirmed PlTB (n = 16), non-confirmed PlTB (n = 17) and non-PlTB (n = 47). The Mycobacterium tuberculosis antigen-specific production of IFN-γ and IP-10 on PB or PF did not show significant differences. However, the basal levels of these biomarkers, as well as the ADA activity on PF, were significantly increased in confirmed PlTB in comparison to non-PlTB group. Receiver operating characteristics curves were performed and the best cut-off points of these three biomarkers were estimated. Their either isolated or combined performances (sensitivity [Se], specificity [Sp], positive predictive value [PPV], negative predictive value [NPV] and accuracy [Acc]) were determined and applied to Venn's diagrams among the groups. Based on the confirmed PlTB cases, IFN-γ showed the best performance of them at a cut-off point of 2.33 IU/mL (Se = 93.8% and Sp = 97.9%) followed by ADA at a cut-off of 25.80 IU/L (Se = 100% and Sp = 84.8%) and IP-10 (Cut-point = 4,361.90 pg/mL, Se = 75% and Sp = 82.6%). IFN-γ plus ADA ((cut-point: 25.80 IU/L)) represent the most accurate biomarker combination (98.4%), showing Se = 93.7%, Sp = 100%, PPV = 100% and NPV = 97.9%. When this analysis was applied in non-confirmed PlTB, 15/17 (88.2%) presented at least two positive biomarkers in combination. CONCLUSION: IFN-γ, IP-10, and ADA in PlTB effusions are significantly higher than in non-PlTB cases. IFN-γ is an excellent rule-in and rule-out test compared to IP-10 and ADA. The combination of IFN-γ and ADA, in a reviewed cut-off point, showed to be particularly useful to clinicians as their positive results combined prompts immediate treatment for TB while both negative results suggest further investigation. |
format | Online Article Text |
id | pubmed-6110466 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-61104662018-09-17 Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-γ, IP-10 and adenosine deaminase Santos, Ana Paula Corrêa, Raquel da Silva Ribeiro-Alves, Marcelo Soares da Silva, Ana Carolina Oliveira Mafort, Thiago Thomaz Leung, Janaína Pereira, Geraldo Moura Batista Rodrigues, Luciana Silva Rufino, Rogério PLoS One Research Article BACKGROUND: Pleural tuberculosis (PlTB) is the most common extrapulmonary manifestation of this infectious disease which still presents high mortality rates worldwide. Conventional diagnostic tests for PlTB register multiple limitations, including the lack of sensitivity of microbiological methods on pleural specimens and the need of invasive procedures such as pleural biopsy performance. In this scenario, the search for biological markers on pleural fluid (PF) has been the target of several studies as a strategy to overcome the limitations of PlTB diagnosis. This study aims to evaluate the use either isolated or in combination with adenosine deaminase (ADA), interferon-gamma (IFN-γ), interferon-gamma inducible protein of 10-kD (IP-10) levels on PF in order to guide an accurate anti-TB treatment in microbiologically non-confirmed cases. METHODS AND FINDINGS: Eighty patients presenting pleural effusion under investigation were enrolled in a cross-sectional study conducted at Pedro Ernesto University Hospital, Rio de Janeiro, RJ, Brazil. Peripheral blood (PB) and PF samples collected from all patients were applied to the commercial IFN-γ release assay, QuantiFERON-TB Gold In-Tube, and samples were analyzed for IFN-γ and IP-10 by immunoassays. ADA activity was determined on PF by the colorimetric method. Based on microbiological and histological criteria, patients were categorized as follow: confirmed PlTB (n = 16), non-confirmed PlTB (n = 17) and non-PlTB (n = 47). The Mycobacterium tuberculosis antigen-specific production of IFN-γ and IP-10 on PB or PF did not show significant differences. However, the basal levels of these biomarkers, as well as the ADA activity on PF, were significantly increased in confirmed PlTB in comparison to non-PlTB group. Receiver operating characteristics curves were performed and the best cut-off points of these three biomarkers were estimated. Their either isolated or combined performances (sensitivity [Se], specificity [Sp], positive predictive value [PPV], negative predictive value [NPV] and accuracy [Acc]) were determined and applied to Venn's diagrams among the groups. Based on the confirmed PlTB cases, IFN-γ showed the best performance of them at a cut-off point of 2.33 IU/mL (Se = 93.8% and Sp = 97.9%) followed by ADA at a cut-off of 25.80 IU/L (Se = 100% and Sp = 84.8%) and IP-10 (Cut-point = 4,361.90 pg/mL, Se = 75% and Sp = 82.6%). IFN-γ plus ADA ((cut-point: 25.80 IU/L)) represent the most accurate biomarker combination (98.4%), showing Se = 93.7%, Sp = 100%, PPV = 100% and NPV = 97.9%. When this analysis was applied in non-confirmed PlTB, 15/17 (88.2%) presented at least two positive biomarkers in combination. CONCLUSION: IFN-γ, IP-10, and ADA in PlTB effusions are significantly higher than in non-PlTB cases. IFN-γ is an excellent rule-in and rule-out test compared to IP-10 and ADA. The combination of IFN-γ and ADA, in a reviewed cut-off point, showed to be particularly useful to clinicians as their positive results combined prompts immediate treatment for TB while both negative results suggest further investigation. Public Library of Science 2018-08-27 /pmc/articles/PMC6110466/ /pubmed/30148839 http://dx.doi.org/10.1371/journal.pone.0202481 Text en © 2018 Santos et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Santos, Ana Paula Corrêa, Raquel da Silva Ribeiro-Alves, Marcelo Soares da Silva, Ana Carolina Oliveira Mafort, Thiago Thomaz Leung, Janaína Pereira, Geraldo Moura Batista Rodrigues, Luciana Silva Rufino, Rogério Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-γ, IP-10 and adenosine deaminase |
title | Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-γ, IP-10 and adenosine deaminase |
title_full | Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-γ, IP-10 and adenosine deaminase |
title_fullStr | Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-γ, IP-10 and adenosine deaminase |
title_full_unstemmed | Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-γ, IP-10 and adenosine deaminase |
title_short | Application of Venn's diagram in the diagnosis of pleural tuberculosis using IFN-γ, IP-10 and adenosine deaminase |
title_sort | application of venn's diagram in the diagnosis of pleural tuberculosis using ifn-γ, ip-10 and adenosine deaminase |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110466/ https://www.ncbi.nlm.nih.gov/pubmed/30148839 http://dx.doi.org/10.1371/journal.pone.0202481 |
work_keys_str_mv | AT santosanapaula applicationofvennsdiagraminthediagnosisofpleuraltuberculosisusingifngip10andadenosinedeaminase AT correaraqueldasilva applicationofvennsdiagraminthediagnosisofpleuraltuberculosisusingifngip10andadenosinedeaminase AT ribeiroalvesmarcelo applicationofvennsdiagraminthediagnosisofpleuraltuberculosisusingifngip10andadenosinedeaminase AT soaresdasilvaanacarolinaoliveira applicationofvennsdiagraminthediagnosisofpleuraltuberculosisusingifngip10andadenosinedeaminase AT mafortthiagothomaz applicationofvennsdiagraminthediagnosisofpleuraltuberculosisusingifngip10andadenosinedeaminase AT leungjanaina applicationofvennsdiagraminthediagnosisofpleuraltuberculosisusingifngip10andadenosinedeaminase AT pereirageraldomourabatista applicationofvennsdiagraminthediagnosisofpleuraltuberculosisusingifngip10andadenosinedeaminase AT rodrigueslucianasilva applicationofvennsdiagraminthediagnosisofpleuraltuberculosisusingifngip10andadenosinedeaminase AT rufinorogerio applicationofvennsdiagraminthediagnosisofpleuraltuberculosisusingifngip10andadenosinedeaminase |